Nadia Barozzi
PhD, MAS ETH NH, PharmD, NLP Master Practitioner
RWE & RWD | Pharmacopidemiology | Clinical Research & Operations | Drug Safety | Evidence Generation
A highly skilled professional in: RWE & RWD, clinical research and operations, drug safety, regulatory requirements, pharmacoepidemiology, medical and health services research, and nutrition sciences. Strong scientific background with a wide skill set.
- Self-motivated, with well-developed scientific knowledge combined with a flexible attitude to work
- Critical thinker with strong analytical skills
- Strong team-player
- Skills developed through work in pharma, CRO, as a contractor, business owner and trainer
- Excellent presentation skills and ability to translate and communicate complex study design and findings to diverse audiences
- Excellent organizational skills developed in a variety of deadline-orientated situations - Self-driven learning.
Get to know me
I have completing a PhD in Pharmacoepidemiology & Health Services Research, and throughout the different experiences in the pharmaceutical industry, I have built a solid scientific background in multiple therapeutic areas and strong clinical operation experience.
As a public health and pharmacoepidemiology professional, I have spearheaded the development, implementation, and monitoring of global epidemiology research projects for new product development and post-marketing surveillance. My contributions include designing epidemiology studies to investigate natural history of disease, treatment patterns, safety signals, and post-authorization safety studies (PASSs).
I have worked with diverse data sources (e.g., THIN, Nordic Registries, PharMetrics, MarketScan, MDV, JMDC, HIRA, SNDS, GePaRD, disease registries), and contributed to clinical protocol design, development, review of statistical analysis plans (SAPs), and signal detection in large adverse event reporting system databases.
I have conducted data landscaping, literature reviews, and authored the epidemiology sections of Periodic Safety Update Reports (PSURs) for known and potential risks as defined in Risk Management Plans (RMPs). Additionally, I have authored regulatory responses, risk management and safety reports, and expert statements.
As the Scientific Data Strategist Director at a leading CRO, I oversee a broad range of activities in the pre-award and post-award phases. My role involves planning integrated evidence generation plans and conducting hybrid studies (primary and/or secondary data collection) throughout different product life cycle stages, including early engagement (Phase II/III), pre-launch (Phase III), and post-marketing (Phase IV). I specialize in large multi-database PASS.
Visit my LinkedIn profile to learn more about my professional background
And about my personal interests...
